S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Total Liabilities Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Total Liabilities
NT$1.8B
CAGR 3-Years
25%
CAGR 5-Years
14%
CAGR 10-Years
4%
Y
YungShin Global Holding Corp
TWSE:3705
Total Liabilities
NT$6B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
6%
Formosa Laboratories Inc
TWSE:4746
Total Liabilities
NT$5.9B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
9%
ScinoPharm Taiwan Ltd
TWSE:1789
Total Liabilities
NT$1.6B
CAGR 3-Years
-1%
CAGR 5-Years
-13%
CAGR 10-Years
-5%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Total Liabilities
NT$17.1B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
23%
Standard Chem & Pharm Co Ltd
TWSE:1720
Total Liabilities
NT$5.9B
CAGR 3-Years
21%
CAGR 5-Years
15%
CAGR 10-Years
10%

See Also

What is SCI Pharmtech Inc's Total Liabilities?
Total Liabilities
1.8B TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Total Liabilities amounts to 1.8B TWD.

What is SCI Pharmtech Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
4%

Over the last year, the Total Liabilities growth was 36%. The average annual Total Liabilities growth rates for SCI Pharmtech Inc have been 25% over the past three years , 14% over the past five years , and 4% over the past ten years .

Back to Top